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Objective: Branched and fenestrated repair has been shown to be effective for treatment of complex aortic aneurysms.
However, the long-term durability of branches is not well reported.
Methods: Prospective data collected for all patients enrolled in a physician-sponsored investigational device exemption trial
for branched and fenestrated endografts were analyzed. Retrospective review of imaging studies and electronic records
was used to supplement the dataset. Incidences of branch stent secondary intervention, stent fracture, migration, branch-
related rupture, and death were calculated. A time-to-event analysis was performed for secondary intervention for any
branch. Univariable and multivariable analyses were performed to identify related variables. Branch instability,
a composite outcome of any branch event, was reported as a function of exponential decay to capture the loss of freedom
from complications over time.
Results: Between the years 2001 and 2010, 650 patients underwent endovascular aortic repair with branched or fenes-
trated devices. Over 9 years of follow-up (mean [standard deviation], 3 [2.3] years), secondary procedures were per-
formed for 0.6% of celiac, 4% of superior mesenteric artery (SMA), 6% of right renal artery, and 5% of left renal artery
stents. Mean time to reintervention was 237 (354) days. The 30-day, 1-year, and 5-year freedom from branch inter-
vention was 98% (95% conﬁdence interval [CI], 96%-99%), 94% (95% CI, 92%-96%), and 84% (95% CI, 78%-90%),
respectively. Death from branch stent complications occurred in three patients, two related to SMA thrombosis and one
due to an unstented SMA scallop. Multivariable analysis revealed no factors as independent predictors of need for branch
reintervention.
Conclusions: Branches, after branched or fenestrated aortic repair, appear to be durable and are rarely the cause of patient
death. The absence of long-term data on branch patency in open repair precludes comparison, yet the lower morbidity and
mortality risk coupled with longer-term durability data will further alter the balance of repair options. (J Vasc Surg
2013;57:926-33.)The published literature for both conventional open
and endovascular thoracoabdominal aneurysm repair is
focused on protection from rupture, survival, and peri-
operative morbidities.1-5 However, as endovascular repair
evolves to become an accepted alternative to open surgery,
it is necessary to reﬁne the indications for use and identify
modes of failure for both modalities, establishing the dura-
bility to guide management.
The lack of systematic follow-up of open surgical repair
makes establishing a historical gold standard for durability
a challenge. The absence of prospective trials for open thor-
acoabdominal repair coupled with the lack of routine
imaging follow-up relegates the use of historical accounts
of data relating to mortality or other sentinel outcomes
such as paraplegia and renal failure.1,3,5 In one 15-yearthe Department of Vascular Surgery, The Cleveland Clinic Foun-
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long-term rate of graft related complications is 15.4%, yet
these data are limited by the absence of systematic imaging
follow-up and the retrospective nature of the studies.6 The
rate of complications is higher in thoracoabdominal aneu-
rysm repair given the need for multiple anastomoses, the
greater extent of tissue dissection, organ ischemia, and
more aggressive disease process, but this has been left
largely unstudied.
The literature for branched and fenestrated endografts
provides some detail about the durability of contemporary
reports of open thoracoabdominal repair. Some series deﬁne
the patency of branches incorporated into the repair to be
approximately 95%, but experience is limited for outcomes
longer than 2 years, and the details do not reﬂect the com-
plex presentation of branch complications.7-13 AU.S. multi-
center trial has 30 patients, with 23 completing 24-month
follow-up and eight renal events.14 In this report, we provide
details on the long-term durability for patients undergoing
complex endovascular aortic aneurysm repair for devices
over an 8-year experience.METHODS
All patients who underwent placement of a branched
or fenestrated endograft under a physician-sponsored in-
vestigational device exemption protocol between 2001
and 2010 were included in this series (ClinicalTrials.gov
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tion and methods of device implantation have been previ-
ously described.4,9,15,16 All patients signed an informed
consent approved by the Investigational Review Board.
Data concerning patient outcomes and information about
imaging end points are included in the database and were
collected prospectively as deﬁned by the study protocol.
Imaging outcome events were independently assessed by
the treating surgeon and a trained vascular imaging specialist
using a high-resolution, contrast-enhanced computed
tomography (CT) scan and were supplemented with infor-
mation from duplex ultrasound studies and abdominal radi-
ography, where appropriate. Criteria for duplex imaging and
methods for CT scan interpretation have been previously
reported.15,16 Any discrepancies were adjudicated by a non-
treating surgeon with expertise in the ﬁeld and knowledge
of the devices. Imaging outcomes reported in this article
conformed to the reporting standards document for branched
and fenestrated aneurysm repair,17 except where the deﬁni-
tions were incomplete and required modiﬁcations as deﬁned
in this document (Fig 1). Care is taken to distinguish between
stent fracture and component separation and to determine
the clinical relevance of the fracture in addition to the
nature of the component separation and are reported
when possible. Because early imaging was lower resolution
and occasionally inadequate to differentiate fracture from
component separation in the setting of an endoleak, the
decision was made to capture all such patients as type III
endoleak a priori and, when possible, modify the diagnosis
at the time of ﬂuoroscopy during a secondary intervention.
A primary end point indicative of branch instability was
created using a composite of data, including branch occlu-
sion, device migration effecting a branch, branch-related
growth, or the need for any secondary intervention (sub-
categorized as celiac, superior mesenteric artery [SMA],
right renal artery, or left renal artery). Occlusion or stenosis
(peak systolic velocity >280 seconds or renal-to-aortic ratio
>4.5) in any branch vessel was noted and dated according
to the ﬁrst imaging evidence of the ﬁnding.15
Time-to-event analysis using Kaplan-Meier curves was
performed for secondary intervention for individual vessels,
for the composite end point, and for individual branch stent
events. An additional time-to-event analysis comparing jux-
tarenal and thoracoabdominal composite outcomes was
performed. Univariable analysis was used to determine asso-
ciation of comorbidities with rupture, migration, or
secondary intervention. Pearson correlation coefﬁcient
analysis was then used to compare agreement between
rate of intervention for stent graft and a model of decay
to establish a decay coefﬁcient to describe the rate of branch
instability for all stent grafts.
RESULTS
In total, 650 patients underwent aneurysm repair with
branched or fenestrated endograft, including 1679 total
branches over 9 years of follow-up [mean (standard devia-
tion [SD]), 3 [2.3] years]. Data analysis was censored after
2010. The demographics of patients are given in Table I.The accountability of patient return for CT imaging was
84% at 24 months.
In total, device migration occurred in seven patients,
but only ﬁve required secondary intervention, of which
four were branch related (three renal and one SMA). There
were 30 of 1679 (1.7%) branch stent occlusions reported in
follow-up: one of 109 celiac stents, three of 333 SMA
stents, 12 of 558 left renal artery stents, and 12 of 553 right
renal artery stents. For these occlusions, there were
11 procedures performed on 12 branches. To demonstrate
the variety of presentations of branch vessel events, all
interventions for SMA stents are listed in Table II and
for renal artery stents in Table III. There were three celiac
artery interventions, all for endoleak and none leading to
death. No celiac occlusion required intervention. For the
SMA, of 26 interventions, 13 were for endoleak and
13 were for stenosis or thrombosis. Despite the critical
nature of this vessel, only nine patients presented with
urgent or symptomatic complications. There were three
deaths caused by branch stent complications, two due to
acute SMA thrombosis and one due to an unstented
SMA scallop. There were no deaths in the renal or celiac
stent reintervention groups. Of the renal artery interven-
tions, 30 were performed for occlusion or stenosis, and
11 in that time period were complete occlusions that could
not be recannulated, which occurred between 33 and
751 days after the index procedure. Endoleak involving
a renal artery branch was the indication for intervention
in 28 patients. Time to intervention for any branch stent
was variable (mean, 237 [354] days) after the index
procedure.
A Kaplan-Meier curve depicting the rate of secondary
intervention in the four branch vessels over the follow-up
period is shown in Fig 2. The ﬁgure shows that the 30-day
freedom from secondary intervention is 98% (95% conﬁ-
dence interval [CI], 96%-99%) and the 5-year freedom
from secondary intervention is 89% (95% CI, 78%-90%).
Univariate analysis to determine factors associated with
the secondary intervention is given in Table IV. Age, male
sex, smoking, heart failure, and lung cancer met the criteria
for inclusion in the multivariate analysis (Table V). No
variables showed a statistically signiﬁcant association for
secondary intervention. However, both smoking (hazard
ratio [HR], 0.6; 95% CI, 0.3-1.0; P ¼ .07) and lung cancer
(HR, 3.2; 95% CI, 0.9-11.3; P ¼ .06) did show a trend
toward signiﬁcance.
The composite outcome of branch instability was used
for the remainder of the analysis. The freedom from branch
instability is presented in Fig 3. The freedom from branch
instability in patients undergoing either juxtarenal or thor-
acoabdominal repair is presented in Fig 4 and shows no
statistical difference between the two populations. Branch
instability was modeled using an exponential decay model
(Fig 5). It was believed that this would better describe
the durability of the device over time rather than absolute
rates of branch vessel loss. The equation of best ﬁt was
FFCO(t) ¼ (0.062*t0.9), where FFCO(t) ¼ freedom
from composite outcome at time t in years.
Table I. Demographics of patients undergoing branched
and fenestrated endografts
Total No. of patients (n) No. (%)
Male 522 (80)
Age at ﬁrst intervention, years 74.4a (8.1)
History of smoking 364 (56)
History of diabetes 119 (18)
History of heart failure 102 (16)
Ejection fraction (n ¼ 418) 55b [IQR, 47-60]
History of hypertension 534 (82)
History of coronary artery disease (stable
or unstable angina, myocardial infarction,
coronary artery bypass graft, or
percutaneous transluminal coronary
angioplasty)
338 (52)
History of aortic or mitral valve
regurgitation
43 (7)
History of arrhythmia/use of pacemaker 170 (26)
History of chronic obstructive pulmonary
disease
213 (33)
History of lung cancer 15 (2)
Elephant trunk repair 10 (2)
Aneurysm repair 74 (11)
IQR, Interquartile range; SD, standard deviation.
aMean (SD).
bMedian.
Fig 1. Schematic diagram of redeﬁnition of endoleaks derived from branch stent pathology. This level of detail is
important because the differences between B, C, D, and E imply different modes of failure. B and C suggest the
branch–main body or branch–branch interface is inadequate, D suggests material fatigue in the branch stent graft, and
E implies pathologic change in aortic morphology that may have resulted from either poor apposition of branch walls or
endoleak causing sac growth from another source.
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Knowledge of the durability of endovascular thora-
coabdominal aneurysm repair will help to reﬁne its indica-
tions for use and focus device improvements. In this study
we analyzed the long-term durability of branched and
fenestrated endografts. Freedom from secondary interven-
tion was 89% at 3 years of follow-up, indicative of a robust
repair. We used a composite end point representative ofbranch instability to document the behavior of branch
stents over time. These results may not be generalizable
to all fenestrated/branch devices because they are linked
to our speciﬁc practice of device planning and advanced
imaging techniques18 coupled with rigorous follow-up.
The long-term branch instability curve can be ﬁt to an
exponential decay model, with a calculated decay constant
of 0.062, which will allow for comparison with popula-
tions at other centers and other methods of aneurysm
repair that incorporate visceral branches.
It would be ideal to compare our outcomes with that of
large series of open aneurysm repair, but branch durability
data from the open literature are not readily available. Kulik
et al19 described the long-term outcome for visceral bypasses
after a change in practice in 2003 where they replaced the
Carrel patch technique for reimplantation of the visceral
vessels with use of a presewn aortic branch graft. Among
the 41 patients in this series, four vessel branch grafts were
used in 29 patients, renal arteries were not reimplanted in
four patients, and three branches were used due to chronic
renal atrophy or previous nephrectomy in the remaining
eight patients. The patency of the branch grafts was 100%
at 1 month, 100% at 1 year, and 98% 6 1.4% at 5 years,
but these estimates only reﬂect the patients who rise to a clin-
ical presentation. Ultimately, the paucity of systematic
follow-up in most reports of open aneurysm repair does
not allow for adequate historical context against which the
durability of endovascular repair can be compared.
Device planning is one aspect that we consider integral
to long-term durability, both with respect to the location
and method of proximal ﬁxation as well as conformation
of visceral branches. We have developed a practice of estab-
lishing proximal landing zones in a region of>2 cm parallel-
walled and thrombus-free aorta and of minimal tortuosity.
Table III. Details of renal artery interventions in this cohort
Category
No. of
patients
Endoleak
vs occlusion
Mean
preoperative
creatinine
Last
recorded
creatinine
Earliest and latest day
from index procedure
to secondary intervention
Diagnostic angio and intervention for occlusion
or stenosis
19 Occlusion/stenosis 1.12 1.35 87-2239
Complete occlusion, recanalization not possible 11 Occlusion/stenosis 1.14 1.90 33-751
Endoleak requiring intervention 28 Endoleak 1.32 1.77 3-1362
Fig 2. Kaplan-Meier curve for secondary interventions in the
entire cohort.
Table IV. Univariable analysis of patient characteristics
associated with secondary intervention
Variable HR (95% CI) P
Age at ﬁrst intervention per 5-year
increase
0.9 (0.8-1.1) .2
Male 0.6 (0.3-1.2) .1
Smoking 0.6 (0.4-1.1) .1
Diabetes 0.8 (0.4-1.7) .5
Heart failure 0.5 (0.2-1.3) .2
Hypertension 1.2 (0.6-2.5) .6
Coronary artery disease 0.7 (0.4-1.3) .3
Aortic valve repair/mitral valve repair 1.2 (0.4-3.2) .8
Arrhythmia/pacemaker 0.7 (0.3-1.3) .3
Chronic obstructive pulmonary disease 1.0 (0.5-1.7) .9
Lung cancer 3.3 (1.0-10.6) .05
Elephant trunk repair 1.9 (0.3-14.1) .5
Aneurysm repair 1.6 (0.7-3.8) .3
CI, Conﬁdence interval; HR, hazard ratio.
Table II. Details of SMA reinterventions in the cohort
Category
No. of
patients Endoleak vs occlusion
Earliest and latest day from index
procedure to secondary intervention
Diagnostic angio with no intervention needed 1 Occlusion/stenosis 1
Diagnostic angio and intervention for occlusion or stenosis 12a Occlusion/stenosis 1-880
Endoleak requiring intervention 13 Endoleak 3-1362
SMA, Superior mesenteric artery.
aThree deaths related to branch complication.
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conventional infrarenal repair, given the lack of conﬁne-
ment to the nonbranched aorta. Initially there was concern
of increasing case complexity as more vessels were incorpo-
rated into the repair. However, we quickly realized that
compromising the landing zone, irrespective of the number
of vessels involved in the repair, posed more problems in the
form of type I endoleak or migration at late follow-up. This
concept evolved during the course of the study. Ultimately,
in extensive aneurysms the landing zone location must be
balanced against the increasing risk of paraplegia as the
repair moves into proximal territories of aorta. For example,
patients with suprarenal or type IV thoracoabdominalaneurysms may not have undergone replacement of the
entire visceral segment early in the study period if a sealing
segment >10 was observed in the visceral segment. Often,
such patients required adjunct balloon expandable stents
within the aneurysm neck to treat endoleaks in conjunction
with secondary stent grafting of some vessels, coupled with
some observed migration triggering an alteration in our
approach (Fig 6). Still there remain concerns about the
extent of coverage and risk of paraplegia,4 yet we advocate
the creation of a sealing segment >20 mm given the poten-
tial disastrous effect that aortic device migration would have
on branches. Despite the use of active ﬁxation proximally,
migration was observed in seven of the patients and affected
branches in all. This led to the need for intervention in
branch stents in ﬁve patients and the eventual loss of one
renal artery. We attribute the low risk of migration to the
placement of the device within a long segment of healthy
Table V. Multivariable analysis of patient characteristics
associated secondary intervention
Variables HR (95% CI) P
Age at ﬁrst intervention per
5-year increase
0.9 (0.7-1.0) .1
Male 0.6 (0.3-1.1) .1
Smoking 0.6 (0.3-1.0) .07
Heart failure 0.5 (0.2-1.3) .1
Lung cancer 3.2 (0.9-11.3) .06
CI, Conﬁdence interval; HR, hazard ratio.
Fig 3. Kaplan-Meier curve for composite outcome (branch
instability) over the follow-up period.
Fig 4. Kaplan-Meier curve for composite outcome (branch
instability) comparing thoracoabdominal aneurysms (TAAA) with
juxtarenal aneurysms.
Fig 5. Exponential decay curve for fenestrated and branched stent
grafts. The equation describing the curve is FFCO(t) ¼
exp(0.062*t0.9), where FFCO(t) ¼ freedom from branch insta-
bility at time t in years.
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sites, and the uncoupling of the downward forces on the
distal bifurcation as previously described.16
The second fundamental of device design that evolved
with the program was the use of side arm branches rather
than fenestrations to treat visceral branches in the setting
of extensive aneurysms. This is a lesson that evolved
more as a result of common sense durability issues than
frequently observed failure (Fig 7). The SMA and celiac
arteries both arise from the anterior aorta and course
downward (celiac) or anteriorly and then downward
(SMA). The vessel size was often variable, and morphology
included small celiac aneurysms, proximal stenosis, and
irregularities attributed to atherosclerotic disease. All such
factors are indicative that a self-expanding stent will likely
perform better than a balloon-expandable stent in such
circumstances. To mate a self-expanding stent one requires
a region of overlap and an analysis of acceptable paths
through which such a stent may traverse. We hypothesized
that it would be optimal to limit the length of such stents
akin to surgical bypass grafts, whereby shorter stent grafts
with larger diameters will likely outperform longer, smaller
stent grafts. Furthermore, we strived to limit the tortuosityof the branch while maximizing the overlap. Thus, the
aortic overlap component of the branches was approxi-
mately 3 cm in length and arose from the posterior aspect
of the device slightly cranial to the takeoff of the target
vessel. This created a straight path for the mating stent
graft, which resulted in a low risk of fracture with such de-
vices (0%). Fortunately, the consistency of the relationship
of the celiac artery and SMA allowed us to use one design
with respect to branch location and orientation after 2008.
However, the renal arteries in such extensive aneurysms
remain troublesome. They frequently are oriented cranially
or directly laterally and often are quite small. This
Fig 6. Main body stent migration and collapse of right renal artery on computed tomography (CT) (A) and digital
ﬁxed imaging (B). Note the main body stents are not parallel, suggesting aneurysmal degeneration in the proximal
landing zone that likely led to migration.
Fig 7. Observed failure of fenestrated branches crossing aneurysmal aorta. Over time, a well-positioned branch within
a fenestration (A) may separate from the main body, leading to endoleak (B and C) and requiring bridge stenting (D).
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coupled with self-expanding stent grafts, as such mating
stent grafts would be forced to assume a total curvature
in excess of 270 degrees and we believe they do not
perform well in vessels that are <6 mm. The added length
of the requisite stent graft to reach the target artery from
high up in the aorta without the potential for creatingkinking coupled with the need for relining of the stents
with stiff stents (eg, the Wallstent; Boston Scientiﬁc,
Natick, Mass) was also a concern. However, Reilly et al20
have used such a technique and recently reported on the
durability of such repairs. We remain unconvinced that
downwardly oriented renal branches are superior to the
fenestrations that we use in conjunction with visceral
JOURNAL OF VASCULAR SURGERY
932 Mastracci et al April 2013branches for such aneurysms. The observed durability of
the renal fenestrations coupled with balloon expandable
stent grafts in our series does not cause us to reconsider
this approach.
Rigorous follow-up is the second fundamental aspect
that affects device durability assessment. The absence of
imaging follow-up does not imply a durable branch. In
spite of the reintervention rate, only three branch stent
complications led to death in the study period. Thus,
survival is not a surrogate for successful branch repair.
Instead, careful surveillance with CT and duplex ultra-
sound scanning15 remains the gold standard for branch
assessment. Asymptomatic endoleaks as detected by such
imaging studies were a challenge to ﬁt into the accepted
model without some changes; hence we have evolved
a new classiﬁcation. We believed it important to have a clas-
siﬁcation system that consistently groups endoleaks from
similar causes (ie, branch graft failure vs main body/main
device failure) into similar groups, thus improving repro-
ducibility and utility of analysis. Currently, the ﬁeld accepts
that type I endoleaks are those that occur after a failure of
the graft–aorta interface, whereas type III endoleaks are
those that occur after a failure of a device–device interface.
Hence, the proposed classiﬁcation system (Fig 1) relies on
these basic principles to sort the variety of endoleaks that
may develop in branched and fenestrated devices. Only in
the last few years have we had sufﬁciently detailed imaging
systems to make these determinations; hence, the entire
cohort has not been evaluated in this way. However, going
forward, this system will provide useful to clinicians and
scientists alike.
Stent fractures are sometimes difﬁcult to detect, even on
optimal imaging studies. Recent work with phantommodels
at areas of high angulation has demonstrated that areas suspi-
cious for fracture may not have any stent pathology (Blayne
Roeder, Cook Inc, personal communication,May 2012). As
such, we have amended our protocol to couple the follow-up
imaging studies with high-magniﬁcation intraoperative
digital images to adjudicate areas of concern whenever
secondary interventions were required.
Outside of the fundamental principles of device design
and rigorous follow-up, the remainder of branch instability
can be attributed to material fatigue, coagulopathy, or pro-
thrombotic diathesis, intimal hyperplasia, and other factors
yet to be identiﬁed. The broad range of time to reinterven-
tion (mean [standard deviation] 237 [354] days) and the
variety of presentations (Tables II and III) emphasize the
dynamic nature of durability. There is not a time when
patients are completely free of risk, and there are a myriad
of permutations of presentation that made comparison of
late and early failures complex. For this reason, we ﬁnd
that reporting the composite outcome of branch insta-
bility, as a function of exponential decay, is the best statis-
tical method for expressing this phenomenon. The
outcome of device instability encompasses more than
reporting branch stent patency or secondary intervention
alone, which has been the tool of previous authors but fails
to capture important events such as migration, treatedthrombosis, or fracture or stenosis requiring stenting.21
Furthermore, the decay constant can be used as a bench-
mark against which we can compare populations from
other institutions or our future outcomes in a simple
fashion, despite the complexity of presentation. Ulti-
mately, both open and endovascular repair will suffer
from compromise of device or implanted graft integrity
at an unknown rate.
There are limitations to the data presented in our
series. This study represents an analysis of experience over
an 8-year period. In that time, there has been a marked
evolution of fenestrated and branch grafts available for
treatment of complex aneurysms. Early experience was
limited to fenestrated grafts for juxtarenal aneurysms;
however, in the more modern experience (in the last 5 years
of this series) the extent of aortic repair increased to aneu-
rysms from the subclavian artery to the iliac bifurcation.
This is reﬂected in the larger number of renal arteries
treated and hence the larger number of renal artery compli-
cations reported in the series, as detailed in previous
publications.15 The classiﬁcation system for describing
late outcomes such as endoleaks or device failure is still
evolving. This coupled with poor image quality in the
early years of this series means that many early complica-
tions remain difﬁcult to classify accurately. Finally, the
U.S. Food and Drug Administration requires that we track
compliance with imaging follow-up only to 24 months.
There likely is a signiﬁcant drop-off after this time. Although
we believe that our imaging follow-up captures many of the
complications because some of our patients reappear after
many years of noncompliance when their local physician
detects a problem, it is possible that some of the patients
lost to follow-up have branch stent complications and go
undetected.CONCLUSIONS
We report our experience with complex endovascular
repair for thoracoabdominal aneurysms, which have reason-
able durability with ongoing surveillance based on protocol
and minor intervention. We believe this provides evidence
that branched and fenestrated endografts are a durable
alternative to open repair in patients with complex aortic
disease if the principles of device design are adhered to
and vigilant follow-up can be ensured.AUTHOR CONTRIBUTIONS
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Submitted Jul 23, 2012; accepted Sep 25, 2012.DISCUSSIONDr Joseph Ricotta (Atlanta, Ga). Congratulations on such
a huge series and really the ﬁrst one to show long-term follow-
up with these cases.
I just have a couple questions regarding the reinterventions. In
the 10-year period, I’m assuming that your group made the tran-
sition from using uncovered branching stents to covered branching
stents and so over that time did you notice a difference in reinter-
ventions, ie, were there more reinterventions earlier with the
uncovered stents vs the covered stents?
And then, what were the most common reasons to intervene?
Were they in-stent stenosis or was it compression or the kinking of
the stent?
And third, what kind of antiplatelet therapy do you give these
patients?
Dr Tara M. Mastracci. Deﬁnitely we have shown with our
renal outcomes that the covered stents do much better long
term than the uncovered stents, and usually it’s due to in-stent
stenosis. So reinterventions were frequently uncovered stents for
those reasons. So we’ve switched to using entirely covered stents
in every distribution.
Our patients are placed on aspirin as a matter of course, but
we don’t speciﬁcally put them on Plavix for any particular reason.
Dr Mark Fillinger (Lebanon, NH). Excellent series. If I
heard you right, you said that on SMA scallops you now stentevery wide scallop? So you do not leave scallops unstented; is
that correct?
Dr Mastracci.We treat SMA single-wide scallops like a fenes-
tration, mostly because of that case which was our ﬁrst branch
death. And so increasingly, as Matt and I and Roy are proctoring
throughout the community, we’re really trying to explain that
single-wide scallops should be treated like a fenestration. Because
if the device moves even a little bit, it has the potential to obstruct.
Dr Fillinger. So does that have implications for the upcoming
commercial rollout for the Cook fenestrated device?
Dr Mastracci. Inasmuch as that we’re encouraging people to
stent their single-wide scallops, yes.
Dr Thomas Forbes (London, Ontario, Canada). Do you
have any information on stent positioning in the vertical position?
The imaging is done while the patient is supine, but what happens
to stent and vessel orientation when the patient is vertical? Do you
have any information on that?
Dr Mastracci. You’re not able to image a patient vertically,
obviously, and we haven’t done anything like that. But it does
pique our interest. Andwe frequently look at the patient’s breathing
cycle to note the range of motion that a stent is going to have to be
put through. And sometimes that does ﬁgure into whether or not
we use a self-expanding stent after a balloon-expandable stent in
a particular tortuous renal, or commonly in the SMA.
